Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Neonatal Hyperinsulinism.

Glaser1, Landau, Permutt

  • 1Department of Endocrinology and Metabolism, Hebrew University, Hadassah Medical Center, Jerusalem, Israel.

Trends in Endocrinology and Metabolism: TEM
|May 14, 1999
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A note on eugenics.

The Eugenics review·2011
Same author

Bowel disturbance.

Case reports. Children's Memorial Hospital (Chicago, Ill.)·2010
Same author

Irritability; excessive perspiration.

Case reports. Children's Memorial Hospital (Chicago, Ill.)·2010
Same author

Pertussis with lung abscess.

Archives of pediatrics·2010
Same author

Enlarged liver and spleen [infectious granuloma of the reticulo-endothelial system].

Case reports. Children's Memorial Hospital (Chicago, Ill.)·2010
Same author

Jaundice; dark urine: light stools.

Case reports. Children's Memorial Hospital (Chicago, Ill.)·2010
Same journal

HDL resuscitates cells from ferroptosis.

Trends in endocrinology and metabolism: TEM·2026
Same journal

2-Methylbutyrylcarnitine (2MBC).

Trends in endocrinology and metabolism: TEM·2026
Same journal

Decoding growth hormone actions on human growth plate stem cells.

Trends in endocrinology and metabolism: TEM·2026
Same journal

Androgen loss backfires: Brain gate for tumor immunity.

Trends in endocrinology and metabolism: TEM·2026
Same journal

Glucocorticoid resistance-induced inflammation drives cardiovascular-kidney-metabolic (CKM) syndrome pathophysiology.

Trends in endocrinology and metabolism: TEM·2026
Same journal

Hippo signalling in cellular and tissue-level metabolism across health and disease.

Trends in endocrinology and metabolism: TEM·2026
See all related articles

Hyperinsulinism in the newborn (HI) causes hypoglycemia, posing diagnostic challenges. Research links mutations in four beta-cell genes to HI, but other genes may also be involved, advancing understanding of pancreatic function.

Area of Science:

  • Endocrinology
  • Genetics
  • Pediatrics

Background:

  • Hyperinsulinism in the newborn (HI) is a significant cause of hypoglycemia, presenting complex diagnostic and therapeutic challenges.
  • Recent advances have identified mutations in four specific beta-cell genes responsible for HI.
  • However, the molecular basis for many HI cases remains unknown, suggesting additional genetic factors.

Purpose of the Study:

  • To explore the genetic underpinnings of hyperinsulinism in the newborn.
  • To enhance the understanding of pancreatic beta-cell physiology through the study of HI molecular biology.
  • To identify potential novel therapeutic targets for hyperinsulinism and related metabolic disorders.

Main Methods:

  • Genetic analysis of beta-cell genes in patients with hyperinsulinism.

Related Experiment Videos

  • Molecular biology studies to elucidate pancreatic beta-cell function.
  • Clinical data review for diagnostic and therapeutic challenges in HI.

    • Main Results:

    • Mutations in four beta-cell genes have been identified as causes of hyperinsulinism.
    • The molecular etiology for a significant proportion of HI patients is yet to be determined.
    • Studies have improved the understanding of pancreatic beta-cell physiology.

    Conclusions:

    • Genetic mutations are key factors in hyperinsulinism in the newborn.
    • Further research is needed to identify all causative genes for HI.
    • Understanding HI's molecular basis may lead to new treatments for hyperinsulinism and non-insulin-dependent diabetes.